Novartis India Introduces Otrivin In Nasal Spray Format

Novartis India has launched Otrivin in a Nasal Spray format. Otrivin will now be available as a topical nasal decongestant in an easy-to-use direct acting spray format in India.

The company said that Otrivin Nasal Spray will be available over-the-counter (OTC) at chemist stores. It acts directly by constricting the blood vessels in the nasal tissues leading to relief from nasal congestion. Otrivin formulation comprises Xylometazoline 0.1%, and is indicated for the symptomatic relief of nasal congestion due to cold, seasonal and perennial allergic rhinitis and sinusitis.

Vineet Singhal, head of OTC Business Unit at Novartis, said: “A common cold can slow down the pace of life. Otrivin nasal spray will help them manage their common cold symptoms more efficiently through a direct acting solution. It acts locally inside the nose within 2 minutes and works for as long as 10 hours.”